• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[不同毒力的普氏立克次体菌株蛋白质的电泳和免疫化学特性]

[Electrophoretic and immunochemical characteristics of proteins of Rickettsia prowazekii strains of various virulence].

作者信息

Eremeeva M E, Lapina E B, Balaeva N M, Ignatovich V F, Belousova L S

出版信息

Mol Gen Mikrobiol Virusol. 1989 May(5):20-6.

PMID:2501676
Abstract

PAAG-electrophoresis of the isogenic pair of Rickettsia prowazekii strains E and Evir lysates demonstrate the similarity in polypeptide tracks. The different electrophoretic mobility of the Mr 30 Kd protein from these strains as compared with the mobility of analogous protein from the standard virulent Breinl strain is registered. In immunoblot experiments the specific rabbit antiserums obtained on the 30th day of infection with the Breinl, E or Evir strains demonstrate the presence of the different main antigens 60 Kd or 70 Kd. The difference evidently reflects the specificity of development of two forms of infection by the strains having different virulence. The surface tris-soluble antigens of Rickettsia prowazekii have the similar polypeptide contents and immunochemical properties. The main component of tris-soluble antigens Mr 130 Kd protein is not strain specific having the common thermolabile epitope.

摘要

对普氏立克次体菌株E和Evir裂解物的同基因对进行聚丙烯酰胺凝胶电泳,结果表明多肽条带具有相似性。记录到与标准强毒株布雷茵尔菌株类似蛋白质的迁移率相比,这些菌株中Mr 30 Kd蛋白质的电泳迁移率不同。在免疫印迹实验中,用布雷茵尔、E或Evir菌株感染第30天获得的特异性兔抗血清显示存在不同的主要抗原60 Kd或70 Kd。这种差异显然反映了具有不同毒力的菌株引发的两种感染形式发展的特异性。普氏立克次体的表面三溶性抗原具有相似的多肽含量和免疫化学性质。三溶性抗原的主要成分Mr 130 Kd蛋白质不是菌株特异性的,具有共同的热不稳定表位。

相似文献

1
[Electrophoretic and immunochemical characteristics of proteins of Rickettsia prowazekii strains of various virulence].[不同毒力的普氏立克次体菌株蛋白质的电泳和免疫化学特性]
Mol Gen Mikrobiol Virusol. 1989 May(5):20-6.
2
Protein antigens of genetically related Rickettsia prowazekii strains with different virulence.具有不同毒力的遗传相关普氏立克次体菌株的蛋白质抗原。
Acta Virol. 1992 Jan;36(1):52-6.
3
Isolation and partial characterization of the M(r) 100 kD protein from Rickettsia prowazekii strains of different virulence.从不同毒力的普氏立克次氏体菌株中分离和部分鉴定100kD分子量的蛋白质
Acta Virol. 1991 Nov;35(6):557-65.
4
Studies of Rickettsia prowazekii antigens in immunoblotting with specific sera of infected white mice.
Mol Gen Mikrobiol Virusol. 1994 Nov-Dec(6):29-33.
5
[Probable nature of Rickettsia prowazekii virulence].[普氏立克次体毒力的可能性质]
Mol Gen Mikrobiol Virusol. 1996 Apr-Jun(2):39-40.
6
A mutation inactivating the methyltransferase gene in avirulent Madrid E strain of Rickettsia prowazekii reverted to wild type in the virulent revertant strain Evir.普氏立克次体无毒力的马德里E菌株中使甲基转移酶基因失活的一个突变,在有毒力的回复突变株Evir中回复为野生型。
Vaccine. 2006 Mar 20;24(13):2317-23. doi: 10.1016/j.vaccine.2005.11.044. Epub 2005 Dec 5.
7
A 29.5 kDa heat-modifiable major outer membrane protein of Rickettsia prowazekii, putative virulence factor, is a peptidyl-prolyl cis/trans isomerase.
IUBMB Life. 2004 Apr;56(4):215-9. doi: 10.1080/15216540410001699321.
8
Interaction of Rickettsia prowazekii strains of different virulence with white rat macrophages.不同毒力的普氏立克次体菌株与白鼠巨噬细胞的相互作用。
Acta Virol. 1995 Sep;39(4):205-209.
9
Restriction endonuclease analysis of the DNA of Rickettsia prowazekii vaccine strain E and its revertant.普氏立克次体疫苗株E及其回复株DNA的限制性内切酶分析
Acta Virol. 1989 Sep;33(5):454-64.
10
Proteomic analysis of Rickettsia prowazekii.普氏立克次体的蛋白质组学分析。
Ann N Y Acad Sci. 2005 Dec;1063:87-9. doi: 10.1196/annals.1355.013.

引用本文的文献

1
Serological response of patients suffering from primary and recrudescent typhus: comparison of complement fixation reaction, Weil-Felix test, microimmunofluorescence, and immunoblotting.原发性和复发性斑疹伤寒患者的血清学反应:补体结合反应、外斐氏试验、微量免疫荧光法及免疫印迹法的比较
Clin Diagn Lab Immunol. 1994 May;1(3):318-24. doi: 10.1128/cdli.1.3.318-324.1994.